| Mr Thomas C Long, MS, LPC | |
|
827 Harrell St, Alma, AR 72921 | |
| (479) 387-4218 | |
| Not Available |
| Full Name | Mr Thomas C Long |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 827 Harrell St, Alma, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992968838 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | P0911071 (Arkansas) | Primary |
| Entity Name | Center For Psychiatric Wellness, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457733099 PECOS PAC ID: 8527373232 Enrollment ID: O20150810002166 |
News Archive
The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on October 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.
A new bioRxiv study by a research group from the University of California Irvine shows in vitro activity and non-toxicity of the first-in-class cyclic peptide that inhibits the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – laying the groundwork for its use in the treatment of coronavirus disease (COVID-19).
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced Annual 2009 financial results ended June 30, 2009.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thomas C Long, MS, LPC 827 Harrell St, Alma, AR 72921-8333 Ph: (479) 387-4218 | Mr Thomas C Long, MS, LPC 827 Harrell St, Alma, AR 72921 Ph: (479) 387-4218 |
News Archive
The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on October 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.
A new bioRxiv study by a research group from the University of California Irvine shows in vitro activity and non-toxicity of the first-in-class cyclic peptide that inhibits the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – laying the groundwork for its use in the treatment of coronavirus disease (COVID-19).
Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced Annual 2009 financial results ended June 30, 2009.
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.
› Verified 7 days ago
Mrs. Roxann Leigh Reed, MS, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1209 Highway 71 N, Alma, AR 72921 Phone: 479-632-1022 | |
Beverly Ann Vanover, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3201 Harmony Rd Apt 14, Alma, AR 72921 Phone: 417-737-9908 | |
Mr. Derrick Adam Wells, Counselor Medicare: Not Enrolled in Medicare Practice Location: 410 London St Apt B, Alma, AR 72921 Phone: 479-650-0185 | |
Greg Dupriest, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1239 Alma North St, Alma, AR 72921 Phone: 479-462-3440 | |
Lindsey Ann Fultz, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1209 Highway 71 N, Alma, AR 72921 Phone: 479-632-1022 Fax: 479-632-1024 |